...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Question on valuing shares from time of spinoff

Thanks.

That is very helpful. Given that I did a transfer in kind in to my RRSP, I will have to record a small capital gain on the Zenith shares as my broker is valuing them at 66 cents each.

bfw

5
Sep 13, 2018 08:08AM
1
Sep 13, 2018 09:28AM
2
Sep 13, 2018 11:34AM
Share
New Message
Please login to post a reply